FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1983056496> ?p ?o ?g. }

• W1983056496 endingPage "82" @default.
• W1983056496 startingPage "78" @default.
• W1983056496 abstract "The shortage of geranylgeranyl-pyrophosphate (GGPP) was associated to an increased IL-1β release in the autoinflammatory syndrome mevalonate kinase deficiency (MKD), a rare inherited disease that has no specific therapy. Farnesyltransferase inhibitors (FTIs) act at the end of mevalonate pathway. Two FTIs, Tipifarnib (Tip) and Lonafarnib (Lon), were therefore evaluated as possible therapeutical choices for the treatment of MKD. FTIs could lead to a redirection of the limited available number of mevalonate intermediates preferentially to GGPP synthesis, eventually preventing the uncontrolled inflammatory response. The effect of Tip and Lon on intracellular cholesterol level (ICL) and on proinflammatory cytokines secretion was evaluated in a cellular model of MKD, chemically obtained treating RAW 264.7 cells with lovastatin (Lova) and alendronate (Ald). The combination of FTIs with the isoprenoid geraniol (GOH) was also tested both in this model and in monocytes isolated from MKD patients. Tip and Lon proved to revert the ICL lowering and to significantly reduce the lipopolysaccharide-induced cytokines secretion in Ald-Lova -RAW 264.7 cells. This anti-inflammatory effect was amplified combining the use of GOH with FTIs. The effect of GOH and Tip was successfully replicated in MKD patients' monocytes. Tip and Lon showed a dramatic anti-inflammatory effect in monocytes where mevalonate pathway was chemically or genetically impaired." @default.
• W1983056496 created "2016-06-24" @default.
• W1983056496 creator A5022227612 @default.
• W1983056496 creator A5045833196 @default.
• W1983056496 creator A5070876800 @default.
• W1983056496 creator A5077006699 @default.
• W1983056496 creator A5090239706 @default.
• W1983056496 creator A5091902364 @default.
• W1983056496 date "2011-07-01" @default.
• W1983056496 modified "2023-09-26" @default.
• W1983056496 title "The Farnesyltransferase Inhibitors Tipifarnib and Lonafarnib Inhibit Cytokines Secretion in a Cellular Model of Mevalonate Kinase Deficiency" @default.
• W1983056496 cites W1950464121 @default.
• W1983056496 cites W1968041403 @default.
• W1983056496 cites W1970980256 @default.
• W1983056496 cites W1996363381 @default.
• W1983056496 cites W2007472966 @default.
• W1983056496 cites W2036116905 @default.
• W1983056496 cites W2046944750 @default.
• W1983056496 cites W2054579613 @default.
• W1983056496 cites W2057228368 @default.
• W1983056496 cites W2063584629 @default.
• W1983056496 cites W2077302626 @default.
• W1983056496 cites W2080441720 @default.
• W1983056496 cites W2081504817 @default.
• W1983056496 cites W2108247214 @default.
• W1983056496 cites W2112940273 @default.
• W1983056496 cites W2114918609 @default.
• W1983056496 cites W2134304734 @default.
• W1983056496 cites W2144974789 @default.
• W1983056496 cites W2164620635 @default.
• W1983056496 cites W2165441042 @default.
• W1983056496 cites W2170405569 @default.
• W1983056496 cites W2171375470 @default.
• W1983056496 cites W2326764800 @default.
• W1983056496 cites W2412438333 @default.
• W1983056496 doi "https://doi.org/10.1203/pdr.0b013e31821b581c" @default.
• W1983056496 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21430599" @default.
• W1983056496 hasPublicationYear "2011" @default.
• W1983056496 type Work @default.
• W1983056496 sameAs 1983056496 @default.
• W1983056496 citedByCount "22" @default.
• W1983056496 countsByYear W19830564962012 @default.
• W1983056496 countsByYear W19830564962013 @default.
• W1983056496 countsByYear W19830564962015 @default.
• W1983056496 countsByYear W19830564962016 @default.
• W1983056496 countsByYear W19830564962017 @default.
• W1983056496 countsByYear W19830564962018 @default.
• W1983056496 countsByYear W19830564962019 @default.
• W1983056496 countsByYear W19830564962020 @default.
• W1983056496 countsByYear W19830564962021 @default.
• W1983056496 countsByYear W19830564962022 @default.
• W1983056496 crossrefType "journal-article" @default.
• W1983056496 hasAuthorship W1983056496A5022227612 @default.
• W1983056496 hasAuthorship W1983056496A5045833196 @default.
• W1983056496 hasAuthorship W1983056496A5070876800 @default.
• W1983056496 hasAuthorship W1983056496A5077006699 @default.
• W1983056496 hasAuthorship W1983056496A5090239706 @default.
• W1983056496 hasAuthorship W1983056496A5091902364 @default.
• W1983056496 hasBestOaLocation W19830564961 @default.
• W1983056496 hasConcept C112243037 @default.
• W1983056496 hasConcept C134651460 @default.
• W1983056496 hasConcept C164027704 @default.
• W1983056496 hasConcept C181199279 @default.
• W1983056496 hasConcept C185592680 @default.
• W1983056496 hasConcept C203014093 @default.
• W1983056496 hasConcept C2776914184 @default.
• W1983056496 hasConcept C2776990775 @default.
• W1983056496 hasConcept C2778396349 @default.
• W1983056496 hasConcept C2778827360 @default.
• W1983056496 hasConcept C2779716203 @default.
• W1983056496 hasConcept C2779982574 @default.
• W1983056496 hasConcept C2780361610 @default.
• W1983056496 hasConcept C49039625 @default.
• W1983056496 hasConcept C502942594 @default.
• W1983056496 hasConcept C55493867 @default.
• W1983056496 hasConcept C57790582 @default.
• W1983056496 hasConcept C71924100 @default.
• W1983056496 hasConcept C98274493 @default.
• W1983056496 hasConceptScore W1983056496C112243037 @default.
• W1983056496 hasConceptScore W1983056496C134651460 @default.
• W1983056496 hasConceptScore W1983056496C164027704 @default.
• W1983056496 hasConceptScore W1983056496C181199279 @default.
• W1983056496 hasConceptScore W1983056496C185592680 @default.
• W1983056496 hasConceptScore W1983056496C203014093 @default.
• W1983056496 hasConceptScore W1983056496C2776914184 @default.
• W1983056496 hasConceptScore W1983056496C2776990775 @default.
• W1983056496 hasConceptScore W1983056496C2778396349 @default.
• W1983056496 hasConceptScore W1983056496C2778827360 @default.
• W1983056496 hasConceptScore W1983056496C2779716203 @default.
• W1983056496 hasConceptScore W1983056496C2779982574 @default.
• W1983056496 hasConceptScore W1983056496C2780361610 @default.
• W1983056496 hasConceptScore W1983056496C49039625 @default.
• W1983056496 hasConceptScore W1983056496C502942594 @default.
• W1983056496 hasConceptScore W1983056496C55493867 @default.
• W1983056496 hasConceptScore W1983056496C57790582 @default.
• W1983056496 hasConceptScore W1983056496C71924100 @default.
• W1983056496 hasConceptScore W1983056496C98274493 @default.
• W1983056496 hasIssue "1" @default.

• next